Gemina Laboratories Ltd.
GLABF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $1 | $83 | $1,156 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $35 | $0 | $0 | $10 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $71 | $53 | $94 | $35 |
| Total Curr. Assets | $106 | $93 | $563 | $1,379 |
| Property Plant & Equip (Net) | $315 | $369 | $318 | $41 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $994 | $994 | $994 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $22 | $0 | $0 | $0 |
| Total NC Assets | $1,332 | $1,364 | $1,312 | $41 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,438 | $1,456 | $1,875 | $1,420 |
| Liabilities | – | – | – | – |
| Payables | $2,856 | $1,667 | $929 | $326 |
| Short-Term Debt | $1,098 | $279 | $43 | $41 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,743 | $890 | $777 | $104 |
| Total Curr. Liab. | $5,698 | $2,836 | $1,748 | $470 |
| LT Debt | $175 | $206 | $198 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $175 | $206 | $198 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $275 | $285 | $241 | $46 |
| Total Liabilities | $5,873 | $3,041 | $1,947 | $476 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $11,986 | $11,241 | $8,147 | $5,622 |
| Retained Earnings | -$20,839 | -$16,765 | -$11,548 | -$5,569 |
| AOCI | $4,418 | $3,894 | $3,329 | $891 |
| Other Equity | $0 | $45 | $0 | $0 |
| Total Equity | -$4,435 | -$1,585 | -$72 | $944 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,438 | $1,456 | $1,875 | $1,420 |
| Net Debt | $1,273 | $484 | $158 | -$1,110 |